German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest ...

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

This work reports the first CMOS molecular electronics chip. It is configured as a biosensor, where the primary sensing element is a single molecule “molecular wire” consisting of a ∼100 GΩ, 25 nm ...

Our previous posts have discussed some of the great end user features we’ve added to the new Visio. For developers, the new Visio supports programmatic access for many of its new features. The new ...

The Trump administration’s new vaccine advisers on Thursday endorsed this fall’s flu vaccinations for just about every ...

Bing Visual Search Bing Visual Search delivers all of Bing’s intelligent image understanding capabilities in a single call, enabling developers to build compelling image applications on the device of ...

Scientists have identified that the molecule cardiotrophin-like cytokine factor 1 (CLCF1) surges through the bloodstream during workouts, particularly resistance training. This protein appears to ...

The global small molecule API market is projected to grow from USD 124.8 billion in 2025 to USD 193.2 billion by 2035, expanding at a steady CAGR of 4.5%. The standard API segment is set to dominate ...

A concise catalytic asymmetric synthesis of idasanutlin (1) was developed in which the key pyrrolidine core, containing four contiguous stereocenters, was constructed via a Ag/MeOBIPHEP promoted [3 + ...

Existing drug discovery pipelines take 5–10 years and cost billions of dollars. Computational approaches aim to sample from regions of the whole molecular and solid-state compounds called chemical ...

Novo will pay Deep Apple up to $812 million, including an unspecified up-front amount and milestone payments, to identify and begin developing drug candidates that go after a new, nonincretin G ...

The U.S. Small Molecule Innovator API CDMO Market offers growth opportunities fueled by rising demand for HPAPIs across therapeutic areas like oncology, driven by FDA approvals and patent ...